AKT1 and urinary bladder carcinoma: These findings are consistent with those of other studies, which demonstrated that UA’s anticancer activity involves downregulating the phosphorylation of Akt in oral, lung, ovarian, breast, prostate, and bladder cancer cells [18,20,21,27,28,82,83].